Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae.
about
Low-cost, high-throughput, automated counting of bacterial coloniesSafety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers.Post hoc analysis of a randomized double-blind trial of the correlation of functional and binding antibody responses elicited by 13-valent and 7-valent pneumococcal conjugate vaccines and association with nasopharyngeal colonization.Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged ≥50 years. An open-label trial.Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines.Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera.Pneumococcal serotypes causing pneumonia with pleural effusion in pediatric patients.Evaluation of multiplex flow cytometric opsonophagocytic assays for determination of functional anticapsular antibodies to Streptococcus pneumoniaeComparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.Antibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.Seroprevalence of Antibody-Mediated, Complement-Dependent Opsonophagocytic Activity against Neisseria meningitidis Serogroup B in England.Pneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice.Impact of the molecular form of immunoglobulin A on functional activity in defense against Streptococcus pneumoniaeImmunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged ≥2 years: an open-label study.Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine formulations with and without aluminum phosphate and comparison of the formulation of choice with 23-valent pneumococcal polysaccharide vaccine in elderly adults: a randomized opeEfficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice.The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.Assignment of Opsonic Values to Pneumococcal Reference Serum 007sp for Use in Opsonophagocytic Assays for 13 Serotypes.Threshold-free estimation of functional antibody titers of a group B streptococcus opsonophagocytic killing assay.Fluorescent multivalent opsonophagocytic assay for measurement of functional antibodies to Streptococcus pneumoniae.Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies.Development and Qualification of an Opsonophagocytic Killing Assay To Assess Immunogenicity of a Bioconjugated Escherichia coli Vaccine.Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus.Creation, characterization, and assignment of opsonic values for a new pneumococcal OPA calibration serum panel (Ewha QC sera panel A) for 13 serotypes.Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput Shigella Serum Bactericidal Assay.
P2860
Q24603906-AA2A32E6-08B1-450D-85A5-73266CF43C0DQ33909172-9B1DE134-4D59-49DF-9A9F-E6CF8AC3412CQ34260869-706065A2-7C53-4643-ADC6-B255E3A1C224Q34291076-6345A27E-D8C7-4534-8BEF-8CE6AF6F2B15Q34429349-F81EEED9-15F6-4FDA-9C2F-0BD14E266950Q34484048-D63424B8-9D6B-4FDB-9CA7-7127AED1E287Q34596528-BF778523-920D-4700-AA77-75D7F693913AQ34601410-5A7BE060-03DB-40E8-93A4-49A7472C8568Q34774773-C0D5CF67-97F9-479D-ADD0-AF59D853BAF7Q35122775-A730968D-A10C-4A37-A2C6-02448F28426FQ35548013-86B4D569-5B20-4A3B-AC00-CBBC65159040Q35783722-659EA567-9CA2-469E-A13F-869AB0882752Q35783761-CEFB9B66-E1E3-4BA8-BBF0-4FD8DA7B90B1Q35855959-C008462C-5B08-4A03-BEF3-F6836AAD8691Q36977893-CC91BD70-D2BC-4436-BBFA-910B36A108AEQ37145037-BA7E807D-5A1D-4F90-BC2B-C3FA66E1C558Q38366436-B4137E41-3ACF-4892-9FEB-422768E577EDQ39100564-2DC2C054-16A3-4660-9078-907B81E3B9EDQ41419149-3C91F870-6A32-40B1-993B-0110F0CC276DQ41834570-D0455402-447A-4345-81C6-FB02E906E576Q41902347-A60A8BF6-9681-4470-B18A-4C73E53A9986Q47103928-9A58A9CE-5017-49A8-B573-1B4FCE624266Q48053443-56B5D0D8-BC4F-442C-84E0-41108965FF11Q54226661-FEE961A7-9736-4E95-A68A-CE5757884716Q55333715-D947C3A7-B142-4DD5-B8F2-DC6D024574BC
P2860
Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae.
@en
type
label
Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae.
@en
prefLabel
Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae.
@en
P2093
P2860
P1476
Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae.
@en
P2093
Branda T Hu
Carol Kirch
Dace V Madore
Sally A Quataert
Sarah Harris
Stephen W Hildreth
Thomas R Jones
Xinhong Yu
P2860
P304
P356
10.1128/CDLI.12.2.287-295.2005
P577
2005-02-01T00:00:00Z